Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Brain Imaging01:14

Brain Imaging

209
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
209
Dementia01:30

Dementia

96
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
96
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

447
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
447

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Genetic architecture of the limbic white matter microstructure in aging and Alzheimer's Disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Individualized mapping of functional brain networks in older adulthood.

Imaging neuroscience (Cambridge, Mass.)·2026
Same author

Circulating lipids are related to longitudinal changes of ATN biomarkers for Alzheimer's disease.

Molecular psychiatry·2026
Same author

Predicting Autopsy-Confirmed Neuropathology across Clinical, Neuroimaging, and CSF Biomarkers using Machine Learning.

bioRxiv : the preprint server for biology·2026
Same author

MIND diet moderates the associations between cerebrovascular and neurodegenerative disease burden and cognition.

Frontiers in nutrition·2026
Same author

Evaluation of an in vivo biomarker of arteriolosclerosis (ARTS) and its associations with cognition and multimodal ATN(V) biomarkers in a cardiometabolic-risk enriched community cohort.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

相关实验视频

Updated: Jun 6, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

94

在痴呆症中进行神经成像.

Shannon L Risacher

    Continuum (Minneapolis, Minn.)
    |December 2, 2024
    PubMed
    概括

    神经成像生物标志物对于诊断和监测像阿尔茨海默氏症这样的神经退行性疾病至关重要. 在MRI和PET成像技术的进步支持新的治疗方法和诊断框架.

    科学领域:

    • 神经学和神经科学 神经学和神经科学
    • 医疗成像医学成像
    • 生物标志物发现发现

    背景情况:

    • 神经退行性疾病影响全球数百万人,需要先进的诊断工具.
    • 神经成像生物标志物是检测,监测和治疗这些疾病的组成部分.
    • 最近的治疗进展,特别是对于阿尔茨海默病,强调了成像的作用.

    研究的目的:

    • 审查关于神经退行性疾病中神经成像的当前文献.
    • 突出最近神经成像技术的发展及其应用.
    • 讨论神经成像与新型治疗策略和诊断框架的整合.

    主要方法:

    • 综述使用结构和功能磁共振成像 (MRI) 的研究.
    • 分析使用正子发射断层扫描 (PET) 和单光子发射计算机断层扫描 (SPECT) 的研究.
    • 基于生物标志物的诊断系统的检查,包括阿尔茨海默病的粉样蛋白,,神经退行 (A/T/N) 框架.

    主要成果:

    • 神经成像测量是诊断各种神经退行性疾病的重要生物标志物.
    • 核磁共振和PET对于阿尔茨海默病新型抗粉样蛋白疗法的适用性和监测至关重要.
    • 基于生物标志物的诊断框架,如A/T/N,正在为各种神经退行性疾病开发.

    更多相关视频

    Using Retinal Imaging to Study Dementia
    09:17

    Using Retinal Imaging to Study Dementia

    Published on: November 6, 2017

    21.6K
    Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
    14:27

    Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

    Published on: June 26, 2013

    15.6K

    相关实验视频

    Last Updated: Jun 6, 2025

    Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
    05:17

    Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

    Published on: April 18, 2025

    94
    Using Retinal Imaging to Study Dementia
    09:17

    Using Retinal Imaging to Study Dementia

    Published on: November 6, 2017

    21.6K
    Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
    14:27

    Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

    Published on: June 26, 2013

    15.6K

    结论:

    • 神经成像在不断变化的神经退行性疾病诊断和管理领域发挥着关键作用.
    • 先进的成像技术与生物框架的整合提高了诊断准确性和治疗监测.
    • 对神经成像的持续研究对于应对神经退行性疾病的全球健康挑战至关重要.